New device zaps remaining cancer cells during breast surgery

NCT ID NCT07206121

Recruiting now Disease control Sponsor: Innoblative Designs, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a device called SIRA-1000 that uses heat to destroy any cancer cells left behind after a lumpectomy for breast cancer. About 10 women aged 50 and older with a specific type of breast cancer will take part. The goal is to see if the device is safe and works well at cleaning up the edges around the removed tumor.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm follicular lymphoma invasive ductal breast carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER BREAST CANCER - INFILTRATING DUCTAL CARCINOMA BREAST-CONSERVING SURGERY ER/PR+HER2NEU GRADE I, II, III

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

University of Texas Medical Branch at Galveston, TX
RECRUITING

Galveston, Texas, 60612, United States

Contact

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••